Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results
29 3월 2024 - 7:39AM
Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading
developer and manufacturer of diagnostic solutions for the
point-of-care and clinical laboratory markets, will report
financial results for the fourth quarter and fiscal year 2023 on
Thursday, April 4, 2024 at 8:00 AM ET.
Conference Call Dial-In & Webcast
Information
Date: |
Thursday, April 4, 2024 |
Time: |
8:00 AM ET |
United States: |
1-877-407-0784 |
International: |
1-201-689-8560 |
Conference ID: |
13745604 |
Call me™: |
https://callme.viavid.com/viavid/?callme=true&passcode=13743417&h=true&info=company-email&r=true&B=6 |
Webcast |
Click here for webcast |
|
|
About Trinity Biotech Trinity Biotech develops,
acquires, manufactures and markets diagnostic systems, including
both reagents and instrumentation, for the point-of-care and
clinical laboratory segments of the diagnostic market. The products
are used to detect infectious diseases and to quantify the level of
Haemoglobin A1c and other chemistry parameters in serum, plasma and
whole blood. Trinity Biotech sells direct in the United States,
Germany, France and the U.K. and through a network of international
distributors and strategic partners in over 75 countries worldwide.
For further information, please see the Company's website:
www.trinitybiotech.com.
Contact: |
Trinity Biotech plcDes
Fitzgerald (353)-1-2769800 |
LifeSci Partners, LLCEric Ribner(1)-646-751-4363E-mail
investorrelations@trinitybiotech.com |
Trinity Biotech (NASDAQ:TRIB)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Trinity Biotech (NASDAQ:TRIB)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024